Celebrating Collaboration and Innovation
We’re proud to have spearheaded the 20th MR-Linac Consortium meeting (Nov 5–7), where the energy and collaboration of this incredible community were on full display. MR-guided radiotherapy is transforming cancer care, and together we’re driving that change—from sharing evidence to accelerating adoption and sparking innovation across more than 100 sites worldwide.
Clinical Highlights from the Meeting
1. Experts in pancreatic cancer now use phrases like “unprecedented survival” and “cure” in the context of locally advanced disease.
2. Curative-intent Direct-to-MRL workflows are expanding beyond prostate SBRT.
3. Five new clinical trial proposals have been submitted for consideration under the HTP: GBM, Ultra-central lung, Pancreas cancer, Hepatocellular carcinoma, and Bladder cancer.
Launch of the Spotlight competition
This initiative is all about raising more awareness of MR-guided radiotherapy. We’re inviting you—and all consortium members—to get creative and help spread the word about the clinical benefits of MRgRT to a broader audience, including referring clinicians, patients, and policymakers.
Collaboration with Rad Chat Podcast
We are thrilled that Rad Chat joined us at the MR-Linac Consortium meeting! Rad Chat @rad__chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology.
Rad Chat is listened to in 130 countries around the world and in the top 1% of podcasts worldwide for content creation.
🎙️ Curious to listen to what Consortium attendees shared with RadChat? Check out the 15 podcasts recorded during the meeting here: https://lnkd.in/efDY7gJ2
